601 related articles for article (PubMed ID: 15949585)
1. Circulating tumour-derived DNA and RNA markers in blood: a tool for early detection, diagnostics, and follow-up?
Bremnes RM; Sirera R; Camps C
Lung Cancer; 2005 Jul; 49(1):1-12. PubMed ID: 15949585
[TBL] [Abstract][Full Text] [Related]
2. Circulating plasma DNA as diagnostic biomarker in non-small cell lung cancer.
Paci M; Maramotti S; Bellesia E; Formisano D; Albertazzi L; Ricchetti T; Ferrari G; Annessi V; Lasagni D; Carbonelli C; De Franco S; Brini M; Sgarbi G; Lodi R
Lung Cancer; 2009 Apr; 64(1):92-7. PubMed ID: 18804892
[TBL] [Abstract][Full Text] [Related]
3. Early detection of lung cancer: clinical perspectives of recent advances in biology and radiology.
Hirsch FR; Franklin WA; Gazdar AF; Bunn PA
Clin Cancer Res; 2001 Jan; 7(1):5-22. PubMed ID: 11205917
[TBL] [Abstract][Full Text] [Related]
4. Detection of microsatellite alterations in plasma DNA of non-small cell lung cancer patients: a prospect for early diagnosis.
Sozzi G; Musso K; Ratcliffe C; Goldstraw P; Pierotti MA; Pastorino U
Clin Cancer Res; 1999 Oct; 5(10):2689-92. PubMed ID: 10537330
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic potential of circulating nucleic acids for oncology.
Goessl C
Expert Rev Mol Diagn; 2003 Jul; 3(4):431-42. PubMed ID: 12877383
[TBL] [Abstract][Full Text] [Related]
6. Early detection of lung cancer using serum RNA or DNA markers: ready for "prime time" or for validation?
Bunn PJ
J Clin Oncol; 2003 Nov; 21(21):3891-3. PubMed ID: 14507944
[No Abstract] [Full Text] [Related]
7. Biological markers in lung cancer: A clinician's perspective.
Tufman A; Huber RM
Cancer Biomark; 2010; 6(3-4):123-35. PubMed ID: 20660959
[TBL] [Abstract][Full Text] [Related]
8. Lung cancer-related genes in the blood.
Sonobe M; Tanaka F; Wada H
Ann Thorac Cardiovasc Surg; 2004 Aug; 10(4):213-7. PubMed ID: 15458371
[TBL] [Abstract][Full Text] [Related]
9. Prognosis of non-small cell lung cancer patients by detecting circulating cancer cells in the peripheral blood with multiple marker genes.
Sher YP; Shih JY; Yang PC; Roffler SR; Chu YW; Wu CW; Yu CL; Peck K
Clin Cancer Res; 2005 Jan; 11(1):173-9. PubMed ID: 15671543
[TBL] [Abstract][Full Text] [Related]
10. Aberrant promoter hypermethylation in serum DNA from patients with silicosis.
Umemura S; Fujimoto N; Hiraki A; Gemba K; Takigawa N; Fujiwara K; Fujii M; Umemura H; Satoh M; Tabata M; Ueoka H; Kiura K; Kishimoto T; Tanimoto M
Carcinogenesis; 2008 Sep; 29(9):1845-9. PubMed ID: 18632757
[TBL] [Abstract][Full Text] [Related]
11. Circulating DNA and lung cancer.
Xue X; Zhu YM; Woll PJ
Ann N Y Acad Sci; 2006 Sep; 1075():154-64. PubMed ID: 17108206
[TBL] [Abstract][Full Text] [Related]
12. Detection and characterization of circulating microsatellite-DNA in blood of patients with breast cancer.
Schwarzenbach H; Müller V; Stahmann N; Pantel K
Ann N Y Acad Sci; 2004 Jun; 1022():25-32. PubMed ID: 15251935
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic developments involving cell-free (circulating) nucleic acids.
Tong YK; Lo YM
Clin Chim Acta; 2006 Jan; 363(1-2):187-96. PubMed ID: 16126188
[TBL] [Abstract][Full Text] [Related]
14. Effects of prolonged storage of whole plasma or isolated plasma DNA on the results of circulating DNA quantification assays.
Sozzi G; Roz L; Conte D; Mariani L; Andriani F; Verderio P; Pastorino U
J Natl Cancer Inst; 2005 Dec; 97(24):1848-50. PubMed ID: 16368947
[TBL] [Abstract][Full Text] [Related]
15. Circulating deoxyribonucleic Acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy.
Gautschi O; Bigosch C; Huegli B; Jermann M; Marx A; Chassé E; Ratschiller D; Weder W; Joerger M; Betticher DC; Stahel RA; Ziegler A
J Clin Oncol; 2004 Oct; 22(20):4157-64. PubMed ID: 15483026
[TBL] [Abstract][Full Text] [Related]
16. The detection of oesophageal adenocarcinoma by serum microsatellite analysis.
Eisenberger CF; Stoecklein NH; Jazra S; Hosch SB; Peiper M; Scheunemann P; Am Esch JS; Knoefel WT
Eur J Surg Oncol; 2006 Nov; 32(9):954-60. PubMed ID: 16584865
[TBL] [Abstract][Full Text] [Related]
17. Analysis of circulating tumor DNA in plasma at diagnosis and during follow-up of lung cancer patients.
Sozzi G; Conte D; Mariani L; Lo Vullo S; Roz L; Lombardo C; Pierotti MA; Tavecchio L
Cancer Res; 2001 Jun; 61(12):4675-8. PubMed ID: 11406535
[TBL] [Abstract][Full Text] [Related]
18. Quantification of free circulating DNA as a diagnostic marker in lung cancer.
Sozzi G; Conte D; Leon M; Ciricione R; Roz L; Ratcliffe C; Roz E; Cirenei N; Bellomi M; Pelosi G; Pierotti MA; Pastorino U
J Clin Oncol; 2003 Nov; 21(21):3902-8. PubMed ID: 14507943
[TBL] [Abstract][Full Text] [Related]
19. Circulating nucleic acids in plasma/serum.
Tsang JC; Lo YM
Pathology; 2007 Apr; 39(2):197-207. PubMed ID: 17454749
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]